Bernard D. Johnson

2.8k total citations · 1 hit paper
27 papers, 2.2k citations indexed

About

Bernard D. Johnson is a scholar working on Organic Chemistry, Oncology and Molecular Biology. According to data from OpenAlex, Bernard D. Johnson has authored 27 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Organic Chemistry, 8 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in Bernard D. Johnson's work include HER2/EGFR in Cancer Research (7 papers), Synthesis and Characterization of Heterocyclic Compounds (5 papers) and Quinazolinone synthesis and applications (5 papers). Bernard D. Johnson is often cited by papers focused on HER2/EGFR in Cancer Research (7 papers), Synthesis and Characterization of Heterocyclic Compounds (5 papers) and Quinazolinone synthesis and applications (5 papers). Bernard D. Johnson collaborates with scholars based in United States, Netherlands and Canada. Bernard D. Johnson's co-authors include M. Brawner Floyd, Allan Wissner, Ramaswamy Nilakantan, Ru Shen, Marvin F. Reich, Hwei‐Ru Tsou, Carolyn Discafani, William Hallett, Yu‐Fen Wang and Xiaoqing Shi and has published in prestigious journals such as Cancer Research, Journal of Medicinal Chemistry and The Journal of Infectious Diseases.

In The Last Decade

Bernard D. Johnson

27 papers receiving 2.1k citations

Hit Papers

Antitumor Activity of HKI-272, an Orally Active, Irrevers... 2004 2026 2011 2018 2004 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Antitumor Activity of HKI-272, an Orally Active, Irreversible Inhibitor of the HER-2 Tyrosine Kinase
    2004 503 citations Sridhar K. Rabindran, Carolyn Discafani et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bernard D. Johnson United States 16 918 864 849 420 294 27 2.2k
Anne M. Hassell United States 21 1.0k 1.1× 585 0.7× 1.6k 1.9× 331 0.8× 313 1.1× 32 2.9k
Helmut Mett Switzerland 28 656 0.7× 736 0.9× 1.7k 2.0× 199 0.5× 135 0.5× 59 3.3k
William T. Windsor United States 23 876 1.0× 302 0.3× 1.5k 1.7× 212 0.5× 226 0.8× 42 2.5k
Patrick Chêne Switzerland 30 2.0k 2.1× 676 0.8× 3.9k 4.6× 253 0.6× 227 0.8× 102 5.1k
James J. Starling United States 26 1.3k 1.4× 207 0.2× 1.1k 1.3× 160 0.4× 335 1.1× 55 2.2k
David P. Baccanari United States 25 354 0.4× 556 0.6× 1.1k 1.3× 88 0.2× 175 0.6× 48 2.1k
Joseph L. Kim United States 14 697 0.8× 230 0.3× 2.9k 3.4× 319 0.8× 133 0.5× 21 3.9k
Sharon Gowan United Kingdom 22 562 0.6× 283 0.3× 2.2k 2.5× 222 0.5× 116 0.4× 36 3.3k
Anna Maria Casazza Italy 29 1.4k 1.5× 782 0.9× 1.2k 1.5× 116 0.3× 331 1.1× 80 2.9k
Ursula Schulze‐Gahmen United States 25 636 0.7× 209 0.2× 1.8k 2.1× 162 0.4× 440 1.5× 38 2.5k

Countries citing papers authored by Bernard D. Johnson

Since Specialization
Citations

This map shows the geographic impact of Bernard D. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernard D. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernard D. Johnson more than expected).

Fields of papers citing papers by Bernard D. Johnson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernard D. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernard D. Johnson. The network helps show where Bernard D. Johnson may publish in the future.

Co-authorship network of co-authors of Bernard D. Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of Bernard D. Johnson. A scholar is included among the top collaborators of Bernard D. Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernard D. Johnson. Bernard D. Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lim, Jean K., Andrea Lisco, David H. McDermott, et al.. (2009). Genetic Variation in OAS1 Is a Risk Factor for Initial Infection with West Nile Virus in Man. PLoS Pathogens. 5(2). e1000321–e1000321. 164 indexed citations
2.
Salaski, Edward J., Girija Krishnamurthy, Weidong Ding, et al.. (2009). Pyranonaphthoquinone Lactones: A New Class of AKT Selective Kinase Inhibitors Alkylate a Regulatory Loop Cysteine. Journal of Medicinal Chemistry. 52(8). 2181–2184. 64 indexed citations
3.
Lim, Jean K., Christine Y. Louie, Carol Glaser, et al.. (2008). Genetic Deficiency of Chemokine Receptor CCR5 Is a Strong Risk Factor for Symptomatic West Nile Virus Infection: A Meta‐Analysis of 4 Cohorts in the US Epidemic. The Journal of Infectious Diseases. 197(2). 262–265. 148 indexed citations
4.
Tsou, Hwei‐Ru, William Hallett, Marvin F. Reich, et al.. (2005). Optimization of 6,7-Disubstituted-4-(arylamino)quinoline-3-carbonitriles as Orally Active, Irreversible Inhibitors of Human Epidermal Growth Factor Receptor-2 Kinase Activity. Journal of Medicinal Chemistry. 48(4). 1107–1131. 246 indexed citations
5.
6.
7.
Wissner, Allan, Dan M. Berger, Diane H. Boschelli, et al.. (2000). 4-Anilino-6,7-dialkoxyquinoline-3-carbonitrile Inhibitors of Epidermal Growth Factor Receptor Kinase and Their Bioisosteric Relationship to the 4-Anilino-6,7-dialkoxyquinazoline Inhibitors. Journal of Medicinal Chemistry. 43(17). 3244–3256. 183 indexed citations
8.
Discafani, Carolyn, Marion L. Carroll, M. Brawner Floyd, et al.. (1999). Irreversible inhibition of epidermal growth factor receptor tyrosine kinase with In Vivo activity by N-[4-[(3-bromophenyl)amino]-6-quinazolinyl]-2-butynamide (CL-387,785). Biochemical Pharmacology. 57(8). 917–925. 84 indexed citations
9.
Reich, Marvin F., Bernard D. Johnson, Robert H. Lenhard, & J. William Hanifin. (1994). Derivatives of D-penicillamine as potential antiarthritic agents. Bioorganic & Medicinal Chemistry Letters. 4(9). 1167–1170. 2 indexed citations
10.
Paul, Rolf, William Hallett, J. William Hanifin, et al.. (1993). Preparation of substituted N-phenyl-4-aryl-2-pyrimidinamines as mediator release inhibitors. Journal of Medicinal Chemistry. 36(19). 2716–2725. 27 indexed citations
11.
Trova, Michael P., Robert E. Babine, Randal A. Byrn, et al.. (1993). Synthesis and biological evaluation of a series of HIV-1 protease inhibitors. Bioorganic & Medicinal Chemistry Letters. 3(8). 1595–1600. 9 indexed citations
12.
Babine, Robert E., Nan Zhang, Steven R. Schow, et al.. (1993). Structure activity studies on pseudo-symmetrical HIV-1 protease inhibitors. Bioorganic & Medicinal Chemistry Letters. 3(8). 1589–1594. 8 indexed citations
13.
Wissner, Allan, Marion L. Carroll, Bernard D. Johnson, et al.. (1992). Analogs of platelet activating factor. 7. Bis-aryl amide and bis-aryl urea receptor antagonists of PAF. Journal of Medicinal Chemistry. 35(26). 4779–4789. 10 indexed citations
14.
Paul, Rolf, John A. Brockman, William Hallett, et al.. (1986). ChemInform Abstract: Imidazo[1,5‐d][1,2,4]triazines as Potential Antiasthma Agents.. Chemischer Informationsdienst. 17(9). 1 indexed citations
15.
Hanifin, J. William, et al.. (1980). ChemInform Abstract: POTENTIAL ANTIARTHRITIC AGENTS. 2. BENZOYLACETONITRILES AND β‐AMINOCINNAMONITRILES. Chemischer Informationsdienst. 11(12). 1 indexed citations
16.
Johnson, Bernard D., et al.. (1976). Aryl-s-tetrazines with antiinflammatory activity. Journal of Medicinal Chemistry. 19(12). 1404–1409. 12 indexed citations
17.
Johnson, Bernard D., et al.. (1975). Novel synthesis of unsymmetrically substituted s‐tetrazines. Journal of Heterocyclic Chemistry. 12(6). 1143–1153. 27 indexed citations
18.
Johnson, Bernard D., et al.. (1971). New Writing in Yugoslavia. Books Abroad. 45(2). 345–345. 1 indexed citations
19.
Johnson, Bernard D., et al.. (1968). Dihydropyrrolo[3,4-c]pyrazoles. Journal of Medicinal Chemistry. 11(3). 616–618. 7 indexed citations
20.
Johnson, Bernard D., et al.. (1968). Syntheses and hypotensive activities of 3-amino-4H-pyrrolo[3,4-c]isoxazoles and derivatives. Journal of Medicinal Chemistry. 11(3). 453–456. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anne M. Hassell Breakdown of academic impact, for papers by Helmut Mett Breakdown of academic impact, for papers by William T. Windsor Breakdown of academic impact, for papers by Patrick Chêne Breakdown of academic impact, for papers by James J. Starling Breakdown of academic impact, for papers by David P. Baccanari Breakdown of academic impact, for papers by Joseph L. Kim Breakdown of academic impact, for papers by Sharon Gowan Breakdown of academic impact, for papers by Anna Maria Casazza Breakdown of academic impact, for papers by Ursula Schulze‐Gahmen
Rankless by CCL
2026